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Introduction: CX3CR1 is a chemokine receptor expressed on various (im-
mune) cell types, and involved in adhesion on and migration of leukocytes 
through epithelial and endothelial cells (1,2). The proportion of CX3CR1+ 
cells within the blood CD4 effector T cell population, has been found to 
be correlated with clinical disease activity in IBD (3). Moreover, blocking 
CX3CR1 has been shown to reduce colitis in mice. This renders CX3CR1 
a promising drug target for IBD and a potential biomarker for disease 
activity. We assessed expression of CX3CR1 on a variety of cell types in the 
blood of IBD patients and healthy controls to find potential target cells for 
CX3CR1-blockade therapy in humans, and questioned whether expression 
of CX3CR1 is associated with histologically proven disease activity in the 
gastrointestinal tract in patients with IBD.
aims & Methods: Peripheral blood from patients with Crohn’s disease (CD, 
n=11), ulcerative colitis (UC, n=11) and healthy controls (HC, n=11) was col-
lected prior to endoscopy. Whole blood was isolated using washing and 
lysis of red blood cells, stained with a panel containing various antibodies 
(CD3, CD8, CD19, CD16, CD14, CD15, CX3CR1, CD56) and subsequently ana-
lyzed using an LSR II FACS analyzer. Disease activity was assessed through 
evaluation of biopsies of macroscopically inflamed areas by a pathologist. 
Using flow cytometry, the proportion of CX3CR1-positive cells as well as 
the level of CX3CR1 expression in a variety of cell types was evaluated. 
Differences between CD, UC and HC, as well as between patients with 
and patients without disease activity in the gastrointestinal tract were as-
sessed.
results: We noted CX3CR1 expression on blood (NK) T cells, NK cells, 
monocytes and granulocytes, but not on B cells. Neutrophils constitute 
the largest proportion of CX3CR1+ cells in the blood (median 3.7% [IQR 
3.3]), whereas within the subpopulations, non-classical monocytes (me-
dian 98% [IQR 2.6]) and NK cells (median 90.3% [IQR 8.7]) had the highest 
proportion of CX3CR1 positive cells. In blood derived from patients with 
histologically active UC, intermediate monocytes showed a significantly 
higher proportion of CX3CR1+ cells (p=0.036), whereas CD4+ NK T cells 
showed upregulation of CX3CR1 on the cell surface (p=0.013), compared to 
patients with UC in remission. In CD, the proportion of CX3CR1+ CD8+ NK 
T cells was higher in patients with inflammation versus patients without 
inflammation (p=0.05).
conclusion: CX3CR1 is expressed on a wide variety of peripheral blood 
cells. Although the proportion of CX3CR1+ cells within the CD4 T cell popu-
lation has previously been reported to be associated with clinical disease 
activity in IBD, we do not find an association between the proportion of 
CX3CR1+ CD4 T cells and histologically proven disease activity in IBD. We do 
find an association between inflammation and CX3CR1+ CD8+ NK T cells in 
CD and CX3CR1+ intermediate monocytes in UC, which highlights the role 
of these cells in IBD. These results provide a baseline for follow-up studies 
on the role of CX3CR1 in IBD.
references: 1. Imai T, Hieshima K, Haskell C, et al. Identification and molec-
ular characterization of fractalkine receptor CX3CR1, which mediates both 
leukocyte migration and adhesion. Cell 1997;91:521-30. 2. Nishimura M, 
Umehara H, Nakayama T, et al. Dual functions of fractalkine/CX3C ligand 
1 in trafficking of perforin+/granzyme B+ cytotoxic effector lymphocytes 
that are defined by CX3CR1 expression. J Immunol 2002;168:6173-80. 3. Ko-
bayashi T, Okamoto S, Iwakami Y, et al. Exclusive increase of CX3CR1+CD28-
CD4+ T cells in inflammatory bowel disease and their recruitment as in-
traepithelial lymphocytes. Inflamm Bowel Dis 2007;13:837-46.
disclosure: Nothing to disclose 
P1700 nO dIfference In The dIsTrIBuTIOn Of PaThOgenIc 
facTOrs fOund In escherIchIa cOLI IsOLaTes frOM PaTIenTs 
WITh crOhn’s dIsease and heaLThy IndIvIduaLs
Siniagina M., Markelova M., Laikov A., Boulygina E., Khusnutdinova D., 
Kharchenko A., Fedorova M., Romanova V., Grigoryeva T.
Kazan Federal University, Kazan, Russian Federation
contact e-Mail address: marias25@mail.ru
Introduction: Dysbiosis of the gut microbiome in Crohn’s disease (CD) pa-
tients is associated with reduced bacterial diversity and higher relative 
abundance of Proteobacteria phylum, in particular Escherichia coli. In re-
cent decades, E. coli is thought to be implicated in CD pathogenesis and 
considered as one of the possible causes of the disease occurrence and 
progression.
aims & Methods: The aim of the study was to characterize E. coli strains 
obtained from diagnosed CD patients and individuals (controls), and to 
evaluate their contribution to the pathogenesis of CD.
E. coli strains were isolated from stool samples of 14 patients and 18 con-
trols. Fecal suspensions were inoculated on selective Endo medium and 
colonies were identified by MALDI Biotyper and serological test. Based on 
quadruplex PCR identification according to Clermont et al. (2013), the colo-
nies were assigned to phylogenetic groups. Ninety seven selected isolates 
were sequenced on MiSeq platform. Reads were assembled using SPAdes 
v.3.11.1 followed by assemblies’ annotation using Prokka v.1.9. Serotypes 
were assigned using SerotypeFinder-2.0 tool. Using MLT ENTEROtest 24N 
kit, the strains were tested for the production of H
2
S and the ability to 
utilize various sugars, polyhydric alcohols, glycosides, and amino acids.
results: Out of 97 sequenced isolates, 33 duplicates were revealed using 
the comparative genome analysis, i.e. isolates sequenced more than once 
due to varying colony phenotypes. Sixty four strains had unique genomes - 
27 isolates from CD patients, and 37 isolates from the control group.
The phylogenetic group distribution did not differ significantly between CD 
patients and controls. However, E. coli strains belonged to phylogroups E/
clade 1 and F were identified only in healthy donors. Clinical significance 
of strains belonging to these groups is not well understood.
The pathogenicity and virulence of E. coli strains were explored by search-
ing for 61 previously reported genes of adhesion and invasion system in 
their genomes. We found no statistically significant difference in these 
genes distribution when comparing isolates from both CD and control 
groups. So, there was no evidence for the association between CD status 
and the presence of pathogenic or virulent genes in E. coli strains. Ac-
cording to the classification of E. coli serotypes, among isolated strains 3 
enteroagregative types (EAEC: O17/O44:H18, O15:H18, O126:H27), 3 entero-
pathogenic types (EPEC: O128ac:H12, O88:H25, O154:H9), and 1 enteroinva-
sive type (O112ac:H16) were found. The distribution of these types did not 
differ significantly between CD and control groups, either, though strains 
of these serological subgroups prevailed in fecal samples from individuals 
with CD and constituted a smaller proportion in healthy ones. Prevalence 
of these strains in CD patients may be associated with the development of 
the disease.
Strains from studied cohorts showed no significant difference in ability to 
catalyze sugars, polyhydric alcohols, glycosides and amino acids. It is of 
interest to note, 3 different strains from one CD patient showed ability to 
produce H
2
S. It is supposed that hydrogen sulfide involves in IBD develop-
ment by disrupting the integrity of the intestinal mucosa.
conclusion: The whole genome analysis of E. coli strains in CD patients 
and healthy controls did not reveal any connection between E. coli viru-
lence and pathogenicity and disease status. It may be assumed that the 
development of the disease is associated with altered interaction between 
the bacteria with certain serotypes and human immune system and their 
balance in community.
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